Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Rational Emotive Behavior Therapy01:24

Rational Emotive Behavior Therapy

Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert Ellis's...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study.

Harm reduction journal·2025
Same author

Sympathetic reactivity to physiological stress is associated with expanded cardiac extracellular volume in humans.

BMC medicine·2025
Same author

Middle-Aged Women With Rett Syndrome: Longitudinal Profile From the British Isles Rett Syndrome Survey and Suggestions for Care.

Journal of applied research in intellectual disabilities : JARID·2025
Same author

A qualitative study of benzodiazepine/z-drug and opioid co-use patterns and overdose risk.

Harm reduction journal·2025
Same author

Review of a specialist Rett syndrome clinic from 2003 to the COVID pandemic: clinic experience and carer perspectives.

Orphanet journal of rare diseases·2024
Same author

Carotid body dysregulation contributes to Long COVID symptoms.

Communications medicine·2024

Related Experiment Video

Updated: Jul 16, 2026

An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System
11:22

An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System

Published on: February 17, 2015

A perspective on "cure" for Rett syndrome.

Angus John Clarke1,2, Ana Paula Abdala Sheikh3

  • 1Institute of Medical Genetics, Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, Wales, UK. clarkeaj@cardiff.ac.uk.

Orphanet Journal of Rare Diseases
|April 4, 2018
PubMed
Summary

Rett syndrome research shows potential for reversing disease processes in mouse models. Cautious optimism is advised, balancing curative hopes with current quality-of-life interventions for patients.

Keywords:
CureExpectationsGene editingGene therapyMECP2Quality of lifeRett syndromeSymptomatic treatment

More Related Videos

A Step by Step Protocol for Subretinal Surgery in Rabbits
12:31

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Related Experiment Videos

Last Updated: Jul 16, 2026

An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System
11:22

An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System

Published on: February 17, 2015

A Step by Step Protocol for Subretinal Surgery in Rabbits
12:31

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Rett syndrome is a debilitating neurological disorder.
  • Reversal of disease processes observed in Mecp2 mouse models offers therapeutic hope.
  • The Rett syndrome community faces challenges in balancing curative research with supportive care.

Purpose of the Study:

  • To discuss the implications of disease reversal in mouse models for Rett syndrome.
  • To address the need for a balanced approach between curative strategies and quality-of-life interventions.
  • To caution against inflated expectations regarding potential cures for Rett syndrome.

Main Methods:

  • Review of existing research on Mecp2 mouse models.
  • Analysis of potential therapeutic approaches for Rett syndrome.
  • Discussion of ethical considerations and clinical trial design.

Main Results:

  • Disease process reversal in Mecp2 mouse models suggests potential for therapeutic intervention in humans.
  • Various therapeutic strategies are under development, but safety and efficacy require careful evaluation.
  • Restoring normal MECP2 gene expression presents potential challenges and risks.

Conclusions:

  • While a cure for Rett syndrome is a long-term goal, current patients may not benefit immediately.
  • Medical and therapy-based interventions to enhance quality of life are crucial and should not be minimized.
  • Clinical trials for novel therapies must be approached with extreme caution and realistic expectations.